Inventor · disambiguated record
Mark E. Wilson
Also filed as: WILSON MARK · WILSON MARK E · WILSON MARK EDWARD
27 granted patents·5 pending applications·787 citations·filing 2002–2024
96Inventor score
Files withSGX PHARMACEUTICALS INC12CHUGAI PHARMACEUTICAL CO LTD6DART NEUROSCIENCE CAYMAN LTD6DART NEUROSCIENCE LLC3ARNOLD WILLIAM D1
Top patents by PatentIndex Score
32 records- 0198US7829558B2Fused ring heterocycle kinase modulatorsSGX PHARMACEUTICALS INC·Filed 2008·Granted Nov 9, 2010·149 cites·35 claims
- 0298US7626021B2Fused ring heterocycle kinase modulatorsSGX PHARMACEUTICALS INC·Filed 2007·Granted Dec 1, 2009·179 cites·11 claims
- 0398US7452993B2Fused ring heterocycle kinase modulatorsSGX PHARMACEUTICALS INC·Filed 2005·Granted Nov 18, 2008·194 cites·31 claims
- 0497US7361763B2Pyrrolo-pyridine kinase modulatorsSGX PHARMACEUTICALS INC·Filed 2005·Granted Apr 22, 2008·63 cites·29 claims
- 0596US7361764B2Pyrrolo-pyridine kinase modulatorsSGX PHARMACEUTICALS INC·Filed 2006·Granted Apr 22, 2008·49 cites·38 claims
- 0695US7582637B2Pyrrolo-pyridine kinase modulatorsSGX PHARMACEUTICALS INC·Filed 2008·Granted Sep 1, 2009·45 cites·32 claims
- 0794US7601839B2Pyrrolo-pyridine kinase modulatorsSGX PHARMACEUTICALS INC·Filed 2008·Granted Oct 13, 2009·41 cites·43 claims
- 0891US7906648B2Pyrrolo-pyridine kinase modulatorsSGX PHARMACEUTICALS INC·Filed 2009·Granted Mar 15, 2011·14 cites·53 claims
- 0987US7709645B2Pyrrolo-pyridine kinase modulatorsSGX PHARMACEUTICALS INC·Filed 2007·Granted May 4, 2010·7 cites·28 claims
- 1087US2025122172A1Substituted pyridine and pyrazine compounds as pde4 inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 1186US7449482B2Piperidine compounds useful as malonyl-CoA decarboxylase inhibitorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2004·Granted Nov 11, 2008·25 cites·5 claims
- 1281US9120770B2Substituted pyridine and pyrazine compounds as PDE4 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Granted Sep 1, 2015·3 cites·30 claims
- 1379US7285562B2Cyanoamide compounds useful as malonyl-CoA decarboxylase inhibitorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2004·Granted Oct 23, 2007·14 cites·15 claims
- 1479US2023075774A1Substituted pyridine and pyrazine compounds as pde4 inhibitorsDART NEUROSCIENCE LLC·Filed 2022·Application pending·0 cites
- 1578US9040692B2Substituted pyridine and pyrazine compounds as PDE4 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Granted May 26, 2015·2 cites·1 claims
- 1674US9573937B2Substituted pyridine and pyrazine compounds as PDE4 inhibitorsDART NEUROSCIENCE (CAYMAN) LTD·Filed 2015·Granted Feb 21, 2017·1 cites·20 claims
- 1773US11279691B2Substituted pyridine and pyrazine compounds as PDE4 inhibitorsDART NEUROSCIENCE LLC·Filed 2019·Granted Mar 22, 2022·0 cites·4 claims
- 1870US7897615B2Cyanoamide compounds useful as malonyl-CoA decarboxylase inhibitorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2007·Granted Mar 1, 2011·1 cites·4 claims
- 1965US2018346448A1Substituted pyridine and pyrazine compounds as pde4 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2018·Application pending·0 cites
- 2064US2016009691A1Substituted pyridine and pyrazine compounds as pde4 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Application pending·0 cites
- 2163US9624200B2Therapeutic piperazinesDART NEUROSCIENCE (CAYMAN) LTD·Filed 2014·Granted Apr 18, 2017·0 cites·21 claims
- 2262US8268994B2Fused ring heterocycle kinase modulatorsARNOLD WILLIAM D·Filed 2009·Granted Sep 18, 2012·0 cites·37 claims
- 2357US7803806B2Pyrimidinyl-thiophene kinase modulatorsSGX PHARMACEUTICALS INC·Filed 2006·Granted Sep 28, 2010·0 cites·3 claims
- 2456US11807620B2Quinazolinone compounds and related compoundsPLEXIUM INC·Filed 2021·Granted Nov 7, 2023·0 cites·24 claims
- 2555US8080665B2Piperidine compounds useful as malonyl-CoA decarboxylase inhibitorsCHENG JIE FEI·Filed 2008·Granted Dec 20, 2011·0 cites·3 claims
- 2653US8927546B2Therapeutic piperazinesKAPLAN ALAN P·Filed 2010·Granted Jan 6, 2015·0 cites·10 claims
- 2752US7786145B2Cyanoguanidine-based azole compounds useful as malonyl-CoA decarboxylase inhibitorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2004·Granted Aug 31, 2010·0 cites·3 claims
- 2850US7977481B2Pyrimidinyl-thiophene kinase modulatorsSGX PHARMACEUTICALS INC·Filed 2010·Granted Jul 12, 2011·0 cites·3 claims
- 2950US7709510B2Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulatorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2002·Granted May 4, 2010·0 cites·8 claims
- 3044US2007173488A1Pyrazolothiazole Protein Kinase ModulatorsSGX PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 3140US8110686B2Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulatorsARRHENIUS THOMAS·Filed 2010·Granted Feb 7, 2012·0 cites·4 claims
- 3240US7723366B2Azole compounds as malonyl-CoA decarboxylase inhibitors for treating metabolic diseasesCHUGAI PHARMACEUTICAL CO LTD·Filed 2002·Granted May 25, 2010·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Mark E. Wilson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →